Nationwide Temporal Trends in Clinical Characteristics and Treatment of Dilated Cardiomyopathy From 2003 to 2013 in Japan　― A Report From Clinical Personal Records ―-Reference-Cited by-同舟云学术

Nationwide Temporal Trends in Clinical Characteristics and Treatment of Dilated Cardiomyopathy From 2003 to 2013 in Japan　― A Report From Clinical Personal Records ―

Published:2023-03-24 Issue:4 Volume:87 Page:500-507
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Tsutsui Yoshitomo¹,Matsushima Shouji¹,Enzan Nobuyuki¹,Noda Eri¹,Shinohara Keisuke¹,Hashimoto Toru¹,Ide Tomomi¹,Kinugawa Shintaro¹,Tsutsui Hiroyuki¹

Affiliation:

1. Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/87/4/87_CJ-22-0554/_pdf

Reference36 articles.

1. 1. Elliott P. Cardiomyopathy: Diagnosis and management of dilated cardiomyopathy. Heart 2000; 84: 106–112, doi:10.1136/heart.84.1.106.

2. 2. Hamaguchi S, Kinugawa S, Tsuchihashi-Makaya M, Goto D, Yamada S, Yokoshiki H, et al. Characteristics, management, and outcomes for patients during hospitalization due to worsening heart failure: A report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD). J Cardiol 2013; 62: 95–101, doi:10.1016/j.jjcc.2013.03.009.

3. 3. Sato N, Kajimoto K, Keida T, Mizuno M, Minami Y, Yumino D, et al. Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND Registry). Circ J 2013; 77: 944–951, doi:10.1253/circj.CJ-13-0187.

4. 4. Shiraishi Y, Kohsaka S, Sato N, Takano T, Kitai T, Yoshikawa T, et al. 9-year trend in the management of acute heart failure in Japan: A report from the National Consortium of Acute Heart Failure Registries. J Am Heart Assoc 2018; 7: e008687, doi:10.1161/JAHA.118.008687.

5. 5. Anker SD, Schroeder S, Atar D, Bax JJ, Ceconi C, Cowie MR, et al. Erratum to “Traditional and new composite endpoints in heart failure clinical trials: Facilitating comprehensive efficacy assessments and improving trial efficiency” [Eur J Heart Fail 2016; 18: 482–489]. Eur J Heart Fail 2016; 18: 727, doi:10.1002/ejhf.591.